Figure A (Levo Ethi Fig1)
Iclevia Kit
Product Images NDC 65862-865
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Iclevia (NDC 65862-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Levo Ethi Fig2)
Figure 3 (Levo Ethi Fig3)
The given text provides information about various studies conducted comparing the use of combination oral contraceptives (COC) with non-use. These studies include NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses’ Health Study I, and Oxford Family Planning Study. The text also includes statistical measures such as Odds Ratio (OR), Relative Risk (RR), and Hazard Ratio (HR) for some of the studies. Additionally, the text mentions Effect Estimate but it is not clear what it refers to.*
Figure 4 (Levo Ethi Fig4)
This document provides different methods of contraception for women and the percentage of effectiveness in preventing pregnancy in one year. It shows the range from fewer than 1 pregnancy per 100 women to 85 or more pregnancies per 100 women. The methods include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no intercourse during the most fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*
Package Label-principal Display Panel (0.15 mg/0.03 mg (91 Tablets Carton))
Package Label-principal Display Panel (0.15 mg/0.03 mg (91 Tablets Pouch))
Levo Ethi Fig7
Levo Ethi Fig8
Not available. The given text seems to be a mixture of random characters, symbols, and words with no clear meaning or context.*
Levo Ethi Fig9
This is a description of a medication called Iclevia™ which is a combination of levonorgestrel and ethinyl estradiol in tablet form. It comes in three extended-cycle wallets, each containing 91 tablets, with 84 white tablets containing 0.15mg levonorgestrel USP and 0.03mg ethinyl estradiol USP and seven green inert tablets. It is used to prevent pregnancy when taken in the prescribed daily doses for 91 consecutive days. It does not protect against sexually transmitted diseases such as HIV. The medication should be stored at room temperature, between 20°C to 25°C. The medication is distributed by Aurobindo Pharma USA, Inc.*
Structure1 (Levo Ethi Str1)
Levonorgestrel is a chemical compound with a molecular weight of 3124 g/mol.*
Structure2 (Levo Ethi Str2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
